Juvenile Idiopathic Arthritis (JIA)

Juvenile Idiopathic Arthritis (JIA) is the indication for 11 drugs in DrugBank. It is covered by 12 curated, structured indications.

Also known as: Arthritis, Juvenile · Arthritis, Juvenile Idiopathic · Juvenile Idiopathic Arthritis · Juvenile Arthritis · Idiopathic Juvenile Arthritis
Classified under: Immune System Diseases
Musculoskeletal and Connective Tissue Diseases
Indicated drugs: Acetylsalicylic acid
Choline magnesium trisalicylate
Cyclosporine
Diclofenac
Etodolac
Ibuprofen
Leflunomide
Meclofenamic acid
Naproxen
Secukinumab
Triamcinolone

Resolves to

Vocabularies

MeSHM0001748ICD-10M08SNOMED CT239796000MedDRA10059176UMLSC3495559

What you can answer from here — as of October 22, 2026

11Indicated drugsWith each drug's targets and mechanism

Listed above

12Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

179Clinical trialsPhase, status and sponsor resolved per trial

1Drug reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Juvenile Idiopathic Arthritis (JIA) share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.